Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.
about
Factors which affect superoxide anion release from rat alveolar macrophagesMechanism of action of the group A streptococcal C5a inactivatorInhibition of elastase enzyme release from human polymorphonuclear leukocytes by N-acetyl-galactosamine and N-acetyl-glucosamineSuperoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolaseRole of cell surface contact in the kinetics of superoxide production by granulocytes.Influence of local anesthetics upon human polymorphonuclear leukocyte function in vitro. Reduction of lysosomal enzyme release and superoxide anion production.Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids.Subnormal sensitivity of neutrophils to complement split product C5a in rheumatoid arthritis: relation to complement catabolism and disease extent.Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytesOxidative response of polymorphonuclear leucocytes to synovial fluids from patients with rheumatoid arthritis.Serum complement component depression during acute adenovirus conjunctivitis.Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms.Assessment of oxidative stress in chronic pancreatitis patients.Role of antibody and complement in the control of Encephalitozoon cuniculi infections by rabbit macrophages.Gonococci-human polymorphonuclear leukocyte interactions: metabolic studies associated with attachment and ingestionInfluence of complement on the chemiluminescent response of human leukocytes to immune complex.Differential alterations in host peripheral polymorphonuclear leukocyte chemiluminescence during the course of bacterial and viral infectionsOuter membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils.Identification of C1q as the heat-labile serum cofactor required for immune complexes to stimulate endothelial expression of the adhesion molecules E-selectin and intercellular and vascular cell adhesion molecules 1.Chemotactic deactivation of human neutrophils: possible relationship to stimulation of oxidative metabolismBb fragment of bovine complement factor B: stimulation of the oxidative burst in bovine monocytes.Effect of viruses on luminol-dependent chemiluminescence of human neutrophilsHuman neutrophil migratory function: modulatory effect of interactions with opsonized particles.The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectivelyQuantitative granulocyte chemiluminescence in the rapid detection of impaired opsonization of Escherichia coli.In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency statesNeutrophil oxidative metabolism in aged humans: a perspective.Normal pregnancy is characterized by systemic activation of the complement system.Increased concentration of the complement split product C5a in acute pyelonephritis during pregnancy.Subnormal activation of phagocytes by complement in chronic inflammatory bowel disease? Neutrophil chemotaxis to complement split product C5a.Novel fluorescence method to visualize antibody-dependent hydrogen peroxide-associated "killing" of liposomes by phagocytes.Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization.Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregationEvidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells.Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins.Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis.Pulmonary response of fifth component of complement-sufficient and -deficient mice to hyperoxia.Anaphylatoxins in preterm and term laborPathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid.
P2860
Q23922142-7607F216-9B88-4886-B487-F6D78B75260CQ24608674-094350A3-B151-4EE2-A74A-D9DBB459C86FQ28285320-2B47656B-3082-4AE6-A426-3A5932A81688Q28322416-B1D9F69D-51E6-45A0-8612-0354D543B60AQ28362314-BA853E10-AD81-4CD5-B4E2-23BCBE32BE49Q28366265-9EE6E096-CBFA-4C89-80E1-8541CEA30DFAQ33461765-9232E92E-05BC-45D2-86EA-F3C3EC13FE5AQ33554462-2FC4D864-85B6-4454-B841-5AF4011FA736Q33556024-08AAB1E1-3B47-4B55-8555-4491566D2B2CQ33556342-D78E7E05-7FB7-4D91-807B-28E53EF95164Q33562925-11766782-5DC0-477A-9430-A8DE09EE4E6BQ33643267-68A3B354-1C3F-4CA4-884E-5130E2046151Q33821838-C16F9EF0-6DC1-4852-80ED-1DBDAF313F2EQ33869273-707CEBEE-992C-41C4-B711-4A188F71E954Q33901270-8FA38BC2-8BF3-497F-80C2-2F7331E35E80Q33904335-D629C21E-0AF0-4AE4-8498-E4893B77FD1BQ33905912-081BAE33-6060-4247-8904-AECCC6776226Q33911589-9DBCACD1-88F3-43AA-854E-D10C7F95BCCCQ33912793-5FBBC4C1-CC01-4464-BB0F-5010ABAE44E1Q33974321-812119F7-53A6-4EFC-A8A3-36C60D2AE59DQ34078061-5A146B80-D39B-4658-9655-543E762F256CQ34081309-384CC3D9-FBA5-4615-92CE-BE0E21BA14CBQ34085084-1602C756-22A8-49A6-A701-EC4CFF4826B3Q34093367-244E66AD-1A78-4F63-B6CB-8649097F328BQ34248005-62D37483-9DCD-4BA9-B00B-5A54BB40BF4BQ34409023-EA739CEB-912C-4D57-887E-8C47298B55CDQ34456745-7922600A-2F80-46C8-96AC-0C28871F505AQ34494857-6383D29D-8409-49F4-9C29-64815FFADFFCQ34499492-FD54356C-2B77-46AD-90E5-383EC98482B0Q34499499-0E1125B2-DCD0-4073-ADB5-3434A7C52FC6Q34526448-A85415DB-3BDC-40AF-928B-0D246D9FE0E9Q34535681-115E4ACD-C4A2-4EF3-A223-78F1F86A610AQ34536313-8B5C001C-1EAA-4858-B65B-95ED55316B5DQ34559309-F95FB12B-326B-43A8-83AE-02BEF93C41A5Q34562509-FC8938A2-007B-434C-9702-E1402B1B7D74Q34562547-CB65A195-C8E3-4F9C-B4AD-DBE28E6EC305Q34575404-7C241EF0-12DB-424C-99FE-BEC7D3ABAA36Q34614450-6F74F19E-4582-474A-A13C-90D5D61B1820Q34653208-C15417C7-F0D7-4CAC-A10C-2FC4FE4D265DQ35204845-DF70F8D9-67A2-4C30-889F-A31D7E1F3CD5
P2860
Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis.
description
1975 nî lūn-bûn
@nan
1975 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Complement and immunoglobulins ...... independently of phagocytosis.
@ast
Complement and immunoglobulins ...... independently of phagocytosis.
@en
Complement and immunoglobulins ...... independently of phagocytosis.
@nl
type
label
Complement and immunoglobulins ...... independently of phagocytosis.
@ast
Complement and immunoglobulins ...... independently of phagocytosis.
@en
Complement and immunoglobulins ...... independently of phagocytosis.
@nl
prefLabel
Complement and immunoglobulins ...... independently of phagocytosis.
@ast
Complement and immunoglobulins ...... independently of phagocytosis.
@en
Complement and immunoglobulins ...... independently of phagocytosis.
@nl
P2093
P2860
P356
P1476
Complement and immunoglobulins ...... independently of phagocytosis.
@en
P2093
P2860
P304
P356
10.1172/JCI108191
P407
P577
1975-11-01T00:00:00Z